The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Indole-3-carbinol Inhibits the Expression of Cyclin-dependent Kinase-6 and Induces a G1 Cell Cycle Arrest of Human Breast Cancer Cells Independent of Estrogen Receptor Signaling
Open accessAbstract
Indole-3-carbinol (I3C), a naturally occurring component of Brassica vegetables such as cabbage, broccoli, and Brussels sprouts, has been shown to reduce the incidence of spontaneous and carcinogen-induced mammary tumors. Treatment of cultured human MCF7 breast cancer cells with I3C reversibly suppresses the incorporation of [3H]thymidine without affecting cell viability or estrogen receptor (ER) responsiveness. Flow cytometry of propidium iodide-stained cells revealed that I3C induces a G1 cell cycle arrest. Concurrent with the I3C-induced growth inhibition, Northern blot and Western blot analyses demonstrated that I3C selectively abolished the expression of cyclin-dependent kinase 6 (CDK6) in a dose- and time-dependent manner. Furthermore, I3C inhibited the endogenous retinoblastoma protein phosphorylation and CDK6 phosphorylation of retinoblastoma in vitro to the same extent. After the MCF7 cells reached their maximal growth arrest, the levels of the p21 and p27 CDK inhibitors increased by 50%. The antiestrogen tamoxifen also suppressed MCF7 cell DNA synthesis but had no effect on CDK6 expression, while a combination of I3C and tamoxifen inhibited MCF7 cell growth more stringently than either agent alone. The I3C-mediated cell cycle arrest and repression of CDK6 production were also observed in estrogen receptor-deficient MDA-MB-231 human breast cancer cells, which demonstrates that this indole can suppress the growth of mammary tumor cells independent of estrogen receptor signaling. Thus, our observations have uncovered a previously undefined antiproliferative pathway for I3C that implicates CDK6 as a target for cell cycle control in human breast cancer cells. Moreover, our results establish for the first time that CDK6 gene expression can be inhibited in response to an extracellular antiproliferative signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson, M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 794
A novel rapid assay for chloramphenicol acetyltransferase gene expression
Neumann, J., Morency, C. A., & Russian, K. O. (1987) · BioTechniques · Cited by 749
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Structural basis of cyclin-dependent kinase activation by phosphorylation
Russo, A. A., Jeffrey, P. D., & Pavletich, N. P. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0896-696 · Cited by 598
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Self-citationHunter, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 550
Redundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi, K., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1112 · Cited by 512
Cell cycle control of DNA replication
Stillman, B. (1996) · Science · doi:10.1126/science.274.5293.1659 · Cited by 507
Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
Leone, G., DeGregori, J., Sears, R., Jakoi, L., & Nevins, J. R. (1997) · Nature · doi:10.1038/387422a0 · Cited by 468
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
Inhibition of polycyclic aromatic hydrocarbon-induced neoplasia by naturally occurring indoles.
Wattenberg, L. W., & Loub, W. D. (1978) · PubMed · Cited by 432
p21--Negative Regulator of the Cell Cycle
Gartel, A. L., Serfas, M. S., & Tyner, A. L. (1996) · Experimental Biology and Medicine · doi:10.3181/00379727-213-44046 · Cited by 407
Premenopausal Breast Cancer Risk and Intake of Vegetables, Fruits, and Related Nutrients
Freudenheim, J. L., Marshall, J. R., Vena, J. E., Laughlin, R., Brasure, J. R., Swanson, M. K., Nemoto, T., & Graham, S. (1996) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/88.6.340 · Cited by 347
Cdk inhibitors: on the threshold of checkpoints and development
Elledge, S. J., & Harper, J. W. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90055-8 · Cited by 320
Schuuring, E., Verhoeven, E., Mooi, W. J., & Michalides, R. J. A. M. (1992) · PubMed · Cited by 317
Effects of dietary indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice
Bradlow, H. L., Michnovicz, J. J., Telang, N. T., & Osborne, M. P. (1991) · Carcinogenesis · doi:10.1093/carcin/12.9.1571 · Cited by 304
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4059 · Cited by 267
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sharma, S., Stutzman, J. D., Kelloff, G. J., & Steele, V. E. (1994) · PubMed · Cited by 264
(1975) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/54.4.985 · Cited by 245
Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol.
Grubbs, C. J., Steele, V. E., Casebolt, T. L., Juliana, M. M., Eto, I., Lm, W., Dragnev, K. H., Kelloff, G. J., & Lubet, R. A. (1995) · PubMed · Cited by 237
Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation
Jellinck, P. H., Gekforkert, P., Riddick, D. S., Okey, A. B., Michnovicz, J. J., & Bradlow, H. L. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90258-x · Cited by 190
The Transcription Factor E2F-1 Is a Downstream Target of RB Action
Qin, X.-Q., Livingston, D. M., Ewen, M., Sellers, W. R., Arany, Z., & Kaelin, W. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.742 · Cited by 188
Induction of Estradiol Metabolism by Dietary Indole-3-carbinol in Humans
Michnovicz, J. J., & Bradlow, H. L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.11.947 · Cited by 181
Costello, J., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Huang, H., & Cavenee, W. K. (1997) · PubMed · Cited by 173
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest.
Ewen, M. E., Oliver, C. J., Sluss, H. K., Miller, S. J., & Peeper, D. S. (1995) · Genes & Development · doi:10.1101/gad.9.2.204 · Cited by 166
Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation
Alessandrini, A., Chiaur, D. S., & Pagano, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400581 · Cited by 158
Morse, M. A., LaGreca, S. D., Amin, S., & Chung, F. (1990) · PubMed · Cited by 146
The molecular epidemiology of P53 gene mutations in human breast cancer
Hartmann, A., Blaszyk, H., Kovach, J. S., & Sommer, S. S. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(96)10043-3 · Cited by 139
Selective Responsiveness of Human Breast Cancer Cells to Indole-3-carbinol, a Chemopreventive Agent
Tiwari, R. K., Guo, L., Bradlow, H. L., TELANG, N. T., & Osborne, M. P. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.2.126 · Cited by 135
Long-term responses of women to indole-3-carbinol or a high fiber diet.
Bradlow, H. L., Michnovicz, J. J., Halper, M., Miller, D. G., Wong, G. Y., & Osborne, M. P. (1994) · PubMed · Cited by 129
Bradfield, C. A., & Bjeldanes, L. F. (1984) · Food and Chemical Toxicology · doi:10.1016/0278-6915(84)90147-9 · Cited by 127
Self-citationLiu, H., Wormke, M., & Safe, S. H. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.23.1758 · Cited by 127
Mitogenic signal transduction in human breast cancer cells
Strobl, J. S., Wonderlin, W. F., & Flynn, D. C. (1995) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00062-3 · Cited by 121
Tamoxifen in the Treatment of Breast Cancer
Legha, S. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-3-219 · Cited by 111
Regulation of CYP1A1 by Indolo[3,2-b]carbazole in Murine Hepatoma Cells
Chen, Y., Riby, J. E., Srivastava, P. K., Bartholomew, J. C., Denison, M. S., & Bjeldanes, L. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22548 · Cited by 108
Self-citationGoya, L., Maiyar, A. C., Ge, Y., & Firestone, G. L. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.9.8247014 · Cited by 105
Self-citationIshida, T., Kobayashi, N., Tojo, T., Ishida, S., Yamamoto, T., & Inoue, J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5527 · Cited by 97
CDK2 Is a Target for Retinoic Acid-Mediated Growth Inhibition in MCF-7 Human Breast Cancer Cells
Teixeira, C., & Pratt, M. A. C. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9977 · Cited by 95
Sánchez, I., Goya, L., Vallerga, A. K., & Firestone, G. L. (1993) · PubMed · Cited by 84
Self-citationMusgrove, E. A., Lee, C. S. L., Cornish, A. L., Swarbrick, A., & Sutherland, R. L. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.1.9869 · Cited by 74
The antiproliferative effect of tamoxifen in breast cancer cells: mediation by the estrogen receptor
Bardon, S., Vignon, F., Derocq, D., et al. (1984) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(84)90004-2 · Cited by 72
Tamoxifen resistance in breast cancer
Wiebe, V. J., Osborne, C. K., Fuqua, S. A. W., & DeGregorio, M. W. (1993) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(93)90008-r · Cited by 70
Minireview: Regulation of Gene Expression by Nuclear Hormone Receptors
Meier, C. A. (1997) · Journal of Receptors and Signal Transduction · doi:10.3109/10799899709036612 · Cited by 64
Baldwin, W. S., & LeBlanc, G. A. (1992) · Chemico-Biological Interactions · doi:10.1016/0009-2797(92)90043-k · Cited by 62
Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
Timmermann, S., Hinds, P. W., & Münger, K. (1997) · PubMed · Cited by 61
Wilcken, N., Sarcevic, B., Musgrove, E. A., & Sutherland, R. L. (1996) · PubMed · Cited by 58
McDanell, R. E., McLean, A. E. M., Hanley, A. B., Heaney, R. K., & Fenwick, G. R. (1989) · Food and Chemical Toxicology · doi:10.1016/0278-6915(89)90130-0 · Cited by 52
G1 Cyclins and Control of the Cell Division Cycle in Normal and Transformed Cells
Hamel, P. A., & Hanley-Hyde, J. (1997) · Cancer Investigation · doi:10.3109/07357909709115767 · Cited by 40
Hirokawa, M., Kuroki, J., Kitabayashi, A., & MIURA, A. B. (1996) · Immunology Letters · doi:10.1016/0165-2478(96)02526-6 · Cited by 33
Cited by
Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis
HIGDON, J., DELAGE, B., WILLIAMS, D., & DASHWOOD, R. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.01.009 · Cited by 1,039
Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., & Leitman, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2446 · Cited by 576
Self-citationMolecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives
Aggarwal, B. B., & Ichikawa, H. (2005) · Cell Cycle · doi:10.4161/cc.4.9.1993 · Cited by 434
The cancer chemopreventive actions of phytochemicals derived from glucosinolates
Hayes, J. D., Kelleher, M. O., & Eggleston, I. M. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-2009-8 · Cited by 404
Indole-3-carbinol as a chemopreventive and anti-cancer agent
Weng, J.-R., Tsai, C.-H., Kulp, S. K., & Chen, C.-S. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.01.033 · Cited by 327
Metadata
- Authors
- Cover, C. M., Hsieh, S. J., Tran, S. H., Hallden, G., Kim, G. S., Bjeldanes, L. F., & Firestone, G. L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 273
- Issue
- 7
- Pages
- 3838-3847
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1979805598
- Cited by
- 282
- References
- 57
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.